The largest database of trusted experimental protocols

Plenti cmv puro dest w118 1 vector

Manufactured by Addgene

The PLenti CMV Puro DEST (w118-1) vector is a lentiviral destination vector designed for gene expression. It contains a CMV promoter for constitutive expression and a puromycin resistance gene for selection of transduced cells. The vector is compatible with the Gateway cloning system, allowing for easy insertion of target genes.

Automatically generated - may contain errors

3 protocols using plenti cmv puro dest w118 1 vector

1

Lentiviral Particle Production for CDC25C and RSK Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
4 × 106 293T cells were seeded in 25-cm2 flasks. Transfection was performed to generate lentiviral particles using a four-plasmid system as per the TRC Library Production and Performance protocols, RNAi Consortium, Broad Institute (19 (link)) and as previously described (17 (link)). CDC25C shRNA constructs were purchased from the Sigma MISSION® shRNA Library, and their respective sequences are listed in supplementary table S2. pLKO.1-shRNA scramble (SCR) vector was obtained from Dr. David M. Sabatini through Addgene (plasmid 1864) as previously described (20 (link)). The pLenti CMV Puro DEST (w118-1) vector was obtained from Eric Campeau through Addgene (plasmid 17452). The Ultimate™ ORFs (Invitrogen) for CDC25C and RSK isoforms was obtained from the Johns Hopkins University HiT Center and an LR reaction (Invitrogen) was performed to construct pLenti Puro DEST (w118-1)-CDC25C. All constructs were sequence verified. The ORF clone IDs of the constructs are – IOH14569 (RSK1.a, variant 1), IOH12130 (RSK1.b, variant 2), IOH63248 (RSK2), IOH3648 (RSK3), IOH36120 (RSK4), and IOH14569 (CDC25C).
+ Open protocol
+ Expand
2

Lentiviral Particle Generation for RSK Knockdown and Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
4 × 106 293T cells were seeded in 25-cm2 flasks, and were transfected to generate lentiviral particles using a four -plasmid system as per the TRC Library Production and Performance protocols, RNAi Consortium, Broad Institute (10 (link)) and as previously described (9 (link)). p90RSK shRNA constructs were purchased from Johns Hopkins University HiT Center, and their respective sequences are listed in supplementary table 2. pLKO.1-shRNA scramble vector was obtained from Dr. David M. Sabatini through Addgene (Addgene plasmid 1864) as previously described (11 (link)). The pLenti CMV Puro DEST (w118-1) vector was obtained from Eric Campeau through Addgene (Addgene plasmid 17452). The Ultimate™ ORFs (Invitrogen) for RSK1-4 were obtained from the Johns Hopkins University HiT Center and an LR reaction (Invitrogen) was performed to construct pLenti Puro DEST (w118-1)-RSK 1-4. All constructs were sequence verified. The ORF clone IDs of the constructs are – IOH46696 (RSK1.a, variant 1), IOH12130 (RSK1.b, variant 2), IOH63248 (RSK2), IOH3648 (RSK3), and IOH36120 (RSK4).
+ Open protocol
+ Expand
3

Lentiviral Transduction of T Cells with MDA-7/IL-24

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pLenti CMV Puro DEST (w118-1) vector (Addgene plasmid # 17452) encoding human MDA-7/IL-24 or the empty vector together with pMD2.G (Addgene plasmid # 12259) and psPAX2 plasmid (Addgene plasmid # 12260) were co-transfected into phoenix cells using Fugene HD Promega (Madison, WI). Lentiviral supernatants containing control lentivirus (LV-vec) or lentivirus expressing MDA-7/IL-24 (LV-mda-7) were collected 48 and 72 h after transfection. Day 5 expanded T cells were transduced with LV-vec or LV-mda-7 (2–3 × 106 cells/mL in 6-well plate at MOI of 5 in the presence of 6 μg/mL polybrene) under centrifugation at 2,000 g for 90 mins at 32 °C. Transduced T cells were cultured in the presence of IL-7 and IL-15 overnight before collection for studies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!